Pregnancy Clinical Trial
Official title:
Vitamin D Status of Pregnant Women and Their Children in Eau Claire, South Carolina: A Prevalence and Supplementation Model for Community Health Care Centers in the U.S.
Science News (October 2004) called vitamin D deficiency a "silent epidemic" in America, with
no group unaffected. Using new guidelines of optimal vitamin D levels, more than 90% of
African American women now suffer from vitamin D deficiency. Deficiency during pregnancy has
profound effects on the developing fetus. Other systems besides bones are affected by
vitamin D deficiency, including an increased risk of autoimmune diseases such as rheumatoid
arthritis, multiple sclerosis, type I diabetes, and certain cancers.
This study proposes to examine and manage vitamin D levels in more than one thousand women
in an underserved population in South Carolina. The women will be from the patient
population seeking OB/GYN and Pediatric services through Eau Claire Cooperative Health
Centers, Inc. (ECCHC), a network of ten clinics in three counties in the center of the state
approximately 70 miles from Charleston, SC. ECCHC is one of approximately 1000 community
health centers supported through Health and Human Services' (HHS) Health Resources and
Services Administration's (HRSA), Bureau of Primary Health Care.
The research objectives for this project will be managed through the Pediatric Nutritional
Sciences Research Center of the Children's Research Institute at the Medical University of
South Carolina, Charleston, SC, in collaboration with ECCHC. The research aims will evaluate
vitamin D levels and possible contributing factors to the levels in 1,000 women. Women who
present to ECCHC within the first trimester of pregnancy will be randomized to one of two
doses of vitamin D supplementation shown to be effective in other groups. Each pregnant
mother will begin supplementation during the 12th week of pregnancy and will be followed
closely throughout pregnancy for one year to determine the effectiveness of supplementation
on vitamin D status, overall health of mother, and of her infant following delivery.
We expect to observe severe vitamin D deficiency in a considerable percentage of the mothers
and their infants who receive care at ECCHC, especially those individuals with darker
pigmentation. When the extent of vitamin D deficiency within each racial/ethnic group is
better defined and their supplementation requirements identified, we will be better able to
establish guidelines for supplementation and health maintenance, and set policy
recommendations for the dietary recommended intake of vitamin D. Those women and their
infants identified as deficient in vitamin D will be important in establishing community
health care policies for vitamin D surveillance and supplementation strategies. The results
will allow us to implement specific dietary and/or medical interventions aimed at correcting
hypovitaminosis D in the population in this study and other similar populations being served
by the more than 1000 community health centers nationally.
With avoidance of sunlight exposure due to lifestyle changes and concerns regarding skin
cancer and the resultant widespread use of sunscreen, very few Americans are meeting their
needs for vitamin D either through skin photosynthesis or dietary intake. A study published
by the Centers for Disease Control (CDC) and our laboratory at the Medical University of
South Carolina (MUSC) revealed that 42% of African American women in their childbearing
years exhibited a deficiency of D vitamin (hypovitaminosis D) (1). Using new guidelines of
optimal vitamin D levels, more than 90% of African American women now suffer from vitamin D
deficiency (2). Science News (October 2004) called vitamin D deficiency a "silent epidemic"
in America, with no group unaffected (3). Deficiency during pregnancy has profound effects
on the developing fetus. Vitamin D deficiency affects other systems besides bones: it is
associated with later, lifelong sequelae, with notable increased risk of autoimmune diseases
such as rheumatoid arthritis (4), multiple sclerosis (5,6), type I diabetes (7,8), and
certain cancers (7,9-14). Prevention and intervention studies only recently have been
undertaken (3). A reexamination of dietary vitamin D requirements of various vulnerable
populations in the U.S. is desperately needed (2,3). As a representative community with a
diverse population, Eau Claire Cooperative Health Centers in South Carolina (ECCHC) serves a
large percentage of African American as well as Caucasian and Hispanic women and children
considered to be at high risk for vitamin D deficiency. ECCHC has eight clinics providing 1o
care services to patients with special emphasis on Pediatric and OB/GYN services. Defining
the prevalence of vitamin D deficiency in this patient population and the optimal vitamin D
supplementation strategies for these women and their infants will become the prototype for
recommendations applicable to other communities throughout the U.S.
In Specific Aim 1, the vitamin D status of a cross-sectional sample of 1000 pregnant women
presenting at ECCHC for their prenatal care will be determined by measuring serum calcium,
phosphorus, intact parathyroid hormone (iPTH), 25(OH)D, the nutritional marker of vitamin D
as a function of ethnicity. Maternal health characteristics, skin pigmentation (using
reflectance spectrophotometry), dietary characteristics (using an established food frequency
questionnaire), and lifestyle profiles (using standardized questionnaires) will be
ascertained as well. Any deficiency noted will lead to specific recommendations for vitamin
D supplementation by the research team, with standardized strategies to monitor status
following initiation of supplementation in Specific Aim 2. Based on extensive preliminary
data, a supplementation regimen will be implemented and its efficacy in achieving optimal
vitamin D status in these women tested in Aim 2: women within three racial groups (African
American, Hispanic and Caucasian) will be stratified into two groups by their initial
25(OH)D level: Group 1, <32 ng/mL (less than optimal vitamin D status) and Group 2, ≥32
ng/mL (optimal vitamin D status). Based on our ongoing NIH study of pregnant women, each
group will be randomized to receive one of two doses starting at 13 weeks' gestation: 2,000
or 4,000 IU vitamin D3/day after a universal one-month 2,000 IU/day dosing run-in period at
12 weeks' balanced by race/ethnicity. The randomization schema allows determination of both
efficacy and safety for those deficient and those replete at entry into the study as a
function of race/ethnicity and season.
Anticipated Results and Future Studies: We expect to observe vitamin D deficiency in a
considerable percentage of the mothers and their newborn infants who receive care at ECCHC,
especially those individuals with darker pigmentation. In Aims 1 & 2, by determining the
prevalence of vitamin D deficiency with each racial/ethnic group, we will establish
guidelines for supplementation and health maintenance, and policy recommendations for the
dietary recommended intake of vitamin D in the U.S. The results will allow us to implement
specific dietary and/or medical interventions aimed at correcting hypovitaminosis D in the
population in this study and other similar populations being served by the more than 1000
community health centers nationally.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Completed |
NCT02520687 -
Effects of Dietary Nitrate in Hypertensive Pregnant Women
|
Phase 1 |